Dr. Hecht is Professor of Medicine and Microbiology/Immunology and Chief, Gastroenterology and Nutrition at Loyola University Chicago. She is the former President of the American Gastroenterological Association. In a guest commentary in cooperation between the American Gastroenterological Association and Healio, Dr. Hecht offers advice on how health care professionals can best discuss probiotics with their patients. See the article
Researchers conclude that fecal profiling of volatile organic compounds (VOC’s) may provide a low cost, non-invasive tool to predict the responses of irritable bowel syndrome (IBS) patients to probiotics and diets low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP’s). Modeling baseline fecal VOC’s, and using key features of VOC profiles, correctly predicted response to
Researchers at the University of California, Davis found that chronic liver inflammation is associated with a Western diet via the type of bacteria present in the gut. “We know the transition from steatosis, or fatty liver, to steatohepatitis (inflammation in the fatty liver) plays a crucial role in liver injury and carcinogenesis,” Yu-Jui Yvonne Wan, professor
